in vitro treatment of leukemic cells from hcl patients with recombinant ifn-alpha-2 ( 5/5 cases ) or ifn-beta ( 4/5 cases ) resulted in a marked inhibition of the bcgf-dependent response .
C1517806
leukemic cells
C0023443
hcl